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ABSTRACT: Information on genetic defects constitutes knowledge of a very intimate nature and 
can change a person's life radically. Knowledge of one's own genetic defects can be a source of
-
 great anxiety even if this information is kept secret. When the confidentiality of this information is 
broken the person is often placed in a very vulnerable position and his/her basic rights are 
threatened. Very serious harm can be done to the person involved. On the other hand, genetic 
information pertaining to one person can have serious implications for others' welfare including 
spouses, children, and extended family members. How ought a genetic researcher/doctor deal with 
the information of genetic defects of his/her patients? 
'"Rev. Fr. E. Busuttil, Hil, SJ, Faculty of Theology, University of Malta, Msida, Malta. 
Introduction 
The methodology of modem medicine tends to be 
restricted to the empirical observations of diseases, the 
scientific research of their causes and the development of 
therapy to overcome or control these causes. A disease 
is often seen as a dysfunction of the human body and 
when this is discovered the disease is considered to be 
'explained'. There is a tendency to forget the personal 
dimension of the disease. This aspect is surely a very 
important one. A disease, especially if it is serious, is 
primarily a personal reality. Persons experience a 
disease with their whole being. It often inflicts pain to 
patients who, in certain situations, may perceive it as a 
threat to their continued existence - not only to their 
lives, but also to their integrity as persons. The pain 
which a patient suffers is often not only physical but 
moral and psychological as well. This is especially so 
when the person feels abandoned by his or her loved 
ones who may project on the suffering sick person their 
fears of suffering and death I. 
1 Knowledge of one's own genetic defects ... 
1.1 ... constitutes intimate knowledge: 
TIle biological nature of every human is untouchable, 
in the sense that it is the constituent of the personal 
identity of the individual throughout the course of his 
history. Each person in his absolutely unique 
singularity, is constituted not only by his spirit, but by 
his body as well. Thus, in the body and through the 
body, one touches the person himself in his concrete 
reality. To respect the dignity of man consequently 
anlOunts to safeguarding this identity of the man ... 2 
Genetic defects may be seen as threats to one's body 
and therefore to one's personal identity and dignity. For 
this reason any information on genetic defects 
constitutes knowledge of a very intimate nature. 
1.2 ... may radically change a person's life: 
For example, if a twenty year old man knows that he 
has the Huntington's gene, he is suddenly faced with a 
stark reality which will accompany him for the rest of his 
life and have a strong influence on his life's important 
decisions. He knows that he will probably show 
symptoms for the disease in his forties and that he will 
die some time later. Will he get married? What will he 
tell his girlfriend? 
1.3 ... may be the source of emotional stress: 
Even if the person is "symptomatically" healthy, he or 
she could be suffering from the moral and psychological 
pain of a "future" disease through the mere knowledge of 
his or her genetic defects. And this knowledge would 
change his or her life'radically. 
Some studies indicate that as many as one in ten 
patients who test positive for the Huntington's disease 
mutation never make a full emotional recovery. In some 
cases they have been so severely depressed that they 
have had to be hospitalized. This is not surprising, given 
that there is currently no cure for the disease. Ponder 
and others3 are concerned that positive tests for breast 
cancer could actually worsen a patient's chances of 
survival by triggering depression. For example, "do they 
become so frightened that they stop [breast] self­
examination?" asks genetic counsellor Barbara 
Biesecker of the National Centre for Human Genome 
Research4 . 
1.4 ... may stem from a false interpretation 
of genetic results 
The 'discovery' of genes determining alcoholism, 
schizophrenia, manic depression and Alzheimer's disease 
have been peer-reviewed and published in leading 
journals. They were hailed in the media as breakthroughs 
- and then they were shown to be wrong. Benno Muller­
Hill states " ... I have little faith in the notion that 
treatment of mental diseases will truly benefit from 
knowledge of the culprit genes and gene products. But I 
have no doubt that diagnosis will flourish. Cheap tests 
will be developed which will allow everyone to be tested 
for the variants of genes determining psychiatric 
ailments or psychic qualities outside the doctor's 
office..."s 
I 
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2.3.3 Racial and Ethnic Discrimination 
Few diseases are common enough in the general 
population to merit carrier screening. Many genetic 
diseases have an especially high incidence in a particular 
ethnic, racial, or religious group. Screening only 
members of such a group involves difficulty in 
determining who is a member of that group and risks 
charges of discrimination. Some of the screening 
programmes of sickle-cell screening carried out in the 
US in the early seventies were politically motivated and 
lacked sufficient expertise, confidentiality and provision 
for the counselling of subjects identified as positive. 
Many states passed laws requiring sickle testing at birth, 
at school entry or prior to marriage, laws leading to 
charges by blacks of attempted genocide. Positive 
individuals often suffered a decreased self-image. 
Positive children were often over-protected by parents. 
Individuals were sometimes discriminated against for 
purposes of marriage , employment or insurancels, 
2.3.4 Other Forms of Stigmatization 
A revealing study of sickle screening programme was 
conducted in Orchomeno, a Greek village where 
marriages were frequently arranged by parents, a 
conceivably ideal arrangement to take into account 
genetic knowledge. Nevertheless carriers were 
stigmatized as undesirable marriage partners, not only 
for other carriers, but for everyone l6 . 
3 Combating Genetic Discrimination: 
3.1 Education 
Education of medical practitioners and the general 
public on genetics in order to eliminate discrimination 
based on fears and prejudices which are without 
foundation due to which some of the genetic 
discrimination occurs. For example, many people do not 
understand that a pre-symptomatic diagnosis showing 
the presence of a genetic defect is not the diagnosis of a 
disease and therefore should not be considered as such. 
Education must include efforts to promote values in 
Society which counter racism and promote human rights 
for all - particularly those suffering from some genetic 
defect!7 . 
3.2 Legislation to protect confidentiality 
Laws are needed to protect confidentiality of genetic 
information . The price paid for services of omnipotent 
computers which store and process all sorts of data about 
individual persons and their affairs is the forfeiture of 
privacy. Medical records, like banking transactions and 
assets, purchases by credit cards, tax returns, are all 
vulnerable to inadvertent disclosure or investigation by 
public authorities ls . 
3.3 Legislation to protect the genetically 
disadvantaged 
Dr. Mark A. Rothstien, a legal expert, asserts that as 
the Human Genome Project progresses, the possibility of 
disclosure of confidential genetic information, coercive 
genetic screening, invasions of privacy, or genetic 
discrimination will arise. Legislators must be vigilant to 
ensure that the legal system, medical ethics, corporate 
culture and public policy definitely reject such 
incursions" 19. 
TIle 1996 Treaty on Bioethics of the Council of 
Europe bans genetic testing for pre-symptomatic 
diagnosis except for medical or research purposes. This 
means that gene testing for insurance and employment 
purposes is banned 20. 
3.4 Confidentiality in Cases of 
Unknown Paternity 
Some very embarrassing, or even catastrophic 
consequences may follow the testing of a man's DNA to 
determine paternity... When infoffi1ed of the non­
paternity of their husbands, some women are reported to 
have maintained a fretful silence rather than face the 
adverse consequences for their families. A woman may 
be put under a torturing strain as she decides whether to 
reveal the shame of infidelity or the shame of being a 
victim of rape to her husband. Depending on her own 
character as well as upon social factors, the DNA 
indetification provides the exact infornlation on which a 
difficult choice may be made21 . 
4 Implications for others 
If the genetic infoffi1ation is initially known only to the 
diagnostician, who is then entitled to know it? The 
person in question? Is anyone else entitled to know? 
And if yes, who has the obligation of communicating 
this to them? The new practice of genetically-directed 
medicine brings more complexity to the answering of 
inescapable questions about diagnosis and prognosis. 
The doctor is challenged, not only to disclose true 
infornlation to the patient for the sake of both the 
patient'S health and the rule of honesty; he or she must 
also exercise prudence and discernment concerning how 
much of the known infornlation to share, what to 
withhold, and with whom to share it. This caution is in 
order for two reasons. First, the doctor's primary 
concern for the patient's "best interest" may mandate a 
limitation on "the whole truth and nothing but the truth" . 
Second, the serious concern for other members of the 
patient's family may impose restrictions. In other words, 
the medical dictum "Do no harm" may collide with the 
rule of telling all the facts of a case. However, this 
collision does not render the physician dumb. Words of 
information and counsel must be spoken despite the 
dilemma22 . 
4.1 Some Guidelines:23 
4.1.1 Informing the Patient: 
TIle doctor is ethically obliged to give sufficient 
infornlation to the patient so that s/he is in a position to 
give or to withhold consent in full awareness of the facts . 
The infornlation given must be understandable and 
include the severity of the illness, the advantage and the 
risks of the proposed intervention , and the consequences 
in refusing it. On the other hand, each individual has the 
right not to be compelled to know about his/her own 
genetic defects. 
4.1.2 Informing Others: 
The communication of knowledge of genetic defects 
without the free and the informed consent of the 
individualls concerned amounts to the breaking of a 
secret. The concentric circles of confidentiality need to 
be defined with respect to the effects on other members 
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of an extended family or offspring conceived out of 
wedlock. At times there may be legitimate cases in 
which the welfare of these persons may imply a strong 
obligation for the person with a serious gene defect to 
disclose his situation to these persons for their own good. 
For example, when a husband or wife discover that they 
have a gene defect which is transmissible to their own 
children. he/she has an obligation to tell his/her spouse, 
and their children. since these must also be involved in 
responsible decisions regarding their future progeny24. 
In those cases where the person with the genetic defect 
does not want to know his/her condition. it may be right 
--, for the medical practitioner to communicate the result 
I 
with his/her next of kin and to explain the implications 
of these results on the family. after obtaining permission 
from the patient. Retrospective screening for other 
members of the family may be recommended if this 
would lead to their greater good. Care must be taken in 
all communications on these matters that they be done in 
a very delicate and sensitive way. taking into account the 
greater good of all involved. 
4.1.3 Genetic Screening 
Some push for legally mandated genetic screening. 
Indeed. in the US neonatal screening of certain diseases 
is mandatory. Arguments made for mandatory screening 
are higher compliance rates. lower cost. timely execution 
and facilitation of record-keeping of incidences and 
outcomes. However. this often goes against the 
informed consent ,md privacy of people and endangers 
their basic rights. Voluntary screening is more in line 
with informed consent and respects the freedom of the 
individual. It allows each person to face his/her own 
responsibility. Voluntary screening may also reduce the 
likelihood of adverse psychological effects if screening 
is preceded by appropriate education about the benefits 
and risks of testing and if consent for testing is truly 
inforrned25 . 
Conclusion 
It is shonsighted to view ethical recommendations as 
being in some way contrary to scientific research and 
progress. Real progress in medicine is one which helps 
individuals and humanity as a whole. Ethical 
considerations in medicine ensure that human dignity is 
protected and that medicine is a tool which fights disease 
and advances the integral good of all involved. Ensuring 
privacy in medicine. and in a special way ensuring it in 
genetically related diseases. is vital for this reason. 
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Commentary on: 
Ethical issues connected with the privacy 
of persons found to have genetic defects 
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"Mr. L.J. German, Karinya, Alfred Camilleri Street, 
Misrah Kola, Attard, BZN 05, Malta. 
Fr. Edgar Busuttil's article highlights the ethical issues 
associated with some aspects of genetic screening and 
provides useful guidelines for those involved in handling 
genetic information. The guidelines provided stress the 
importance of obtaining the patient's consent before 
disclosure of such information to third parties and are 
consonant with the guidelines on informed consent 
recently issued by Malta's Bioethics Consultative 
Committee l . 
In their relationships with patients, health care 
professionals assume ethical obligations: to respect their 
autonomy, to act in their best interests (beneficence), to 
avoid doing them harm (non-maleficence) and to act 
with justice. These ethical principles, as outlined by 
Beauchamp and Childress2, make it possible to ethically 
evaluate a vast array of clinical situattons. The main 
ethical issues which are likely to arise in handling 
genetic information are those of confidentiality and 
consent, both of which emanate from the principle of 
respect for the patient's autonomy. 
Genetic information is information of a very intimate 
nature and should, therefore, be handled with due 
discretion and sensitivity. That is because such 
information is not only a potential source of anxiety for 
the patient, but also because it may have serious 
implications for other members of the patient'S family. 
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From the viewpoint of professional ethics, a doctor's 
obligation to safeguard confidentiality in respect of such 
information sterns from the general Hippocratic 
obligation not to divulge clinical infom1ation to third 
parties without the patient's consent. 
Though universally acknowledged as an important 
ethical principle in the practice of Medicine, 
confidentiality is by no means an absolute obligation. 
There may be instances when this principle may conflict 
with others forcing the doctor to prioritise his ethical 
obligations. Faced with such a dilemma, the doctor may 
rightly decide that the patient'S right to confidentiality 
should defer to the rights of other persons. Exceptions 
such as these must always be justified on the principle of 
non-maleficence and never by appeals to medical 
paternalism which, in this day and age, is regarded as an 
anachronism3. Respect for the patient's autonomy would 
still dictate that in such cases, every effort be made to 
obtain the patient'S permission before genetic 
information is disclosed to others. 
There is increasing concern that some 1l1surance 
companies might, in future, insist on compulsory genetic 
testing for certain diseases before undertaking to provide 
health insurance cover. Information about genetic 
defects which is already known to a person before 
applying for insurance, would be expected to be revealed 
along with other relevant information of a medical 
nature4 It is likely, however, that demands for 
compulsory screening as a precondition for insurance 
will be resisted. There is obviously a need for guidelines 
to be drawn up to protect the interests of insurance 
applicants and to ensure ethical practice on the part of 
insurance companies. 
With the increasing identification of genetic 
predisposition to certain diseases, there is also concern 
that prospective employees may, in future, be required to 
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l 
undergo genetic screening in order to identify those most 
at risk of developing adverse reactions in their place of 
work. Compulsory genetic screening not only goes 
against the grain of personal autonoiny but also violates 
the basic right to privacy. Here again, the need is felt for 
guidelines to bring appropriate control to this area5. 
Legislation may be necessary to protect the 
confidentiality of stored clinical information about 
individuals from inadvertent disclosure and access by 
unauthorized personnel. It is sincerely hoped that the 
government will deal with these important matters 
without delay. 
f Commentary on: 
Ethical issues connected with the privacy of 
persons found to have genetic defects. 
Alfred Cuschieri* 
>I< Prof. A. Cuscieri, 
Department of Anato(1)y, University of Malta, Msida, Malta 
It is now universally agreed that good medical 
practice, and particularly that involving genetics, should 
respect the privacy of the . individual and the 
confidentiality of data.. There is increasing awareness of 
the importance of paying due attention to the 
psychological and social implications of disease 
conditions and of involving patients as much as possible 
in decision making through informed consent . The 
general medical ethical principles apply also to genetics, 
which, in addition, involve some situations that may 
present special ethical problems. 
The main problems stem from the fact that genetic 
diseases affect families rather than individuals. In 
addition to the doctor-patient relationship, third parties 
are almost invariably involved. Each of the three parties 
has its own set of responsibilities, rights and limitations, 
which in fact constitute' most of the ethical aspects of 
genetics. Clearly the ethical issues would be quite 
complex and it is important to distinguish clearly the 
ethical implications relating to the doctor, the affected 
individual and third parties. 
Respect for the person - Confidentiality 
and informed consent 
Medical practitioners are bound to maintain 
confidentiality and ensure their patients have been well 
informed prior to undertaking genetic investigations. 
Genetic disorders often cause great psychological 
distress because they directly affect the person's future 
prospects regarding marriage, childbearing, employment 
and other social aspects of life. Attention to these 
psychosocial implications is an integral part of genetic 
counselling that should precede most genetic diagnostic 
tests. In fact the counselling procedure prior to pre­
symptomatic testing for genetic diseases such as 
Huntington's disease routinely involves a psychologist as 
well as a geneticist and extends over two or three 
sessions. TIlese procedures ensure respect for the person 
who is undertaking genetic tests. 
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To whom should genetiC information be given? 
One of the main problems in genetics concerns giving 
infornlation to third parties, whether relatives at risk, 
commercial insurance or employment companies, As a 
general rule, all inforn1ation regarding the results of any 
investigation belong exclusively to the individual 
concerned and cannot be divulged to relatives or other 
third parties without his or her explicit consent. 
Should information be given to relatives? 
Problems arise if the genetic condition also imposes a 
risk on other family members. Is it the doctor's duty to 
inform relatives at risk? This is a very complex situation 
that cannot be generalized upon. At one extreme the 
patient may request that the condition of his test result is 
not divulged, even to close relatives. Such a request 
must be strictly honoured. However, in most cases 
individuals are willing to co-operate an'd to infornl other 
members of their families including prospective 
husband/wife that they could be at risk. This is the duty 
of the individuals . The doctor is responsible for advising 
the individuals that their families might be at risk and 
that' they can be offered genetic counselling and testing if 
they wish. In most cases it would be definitely unethical 
for a doctor to take it upon himself or herself to identify 
and infornl relatives at risk. The main objection would 
be that this would be infringing on the privacy of the 
relatives by obtaining information about them without 
their prior consent, by telling them about a situation that 
they might have preferred not to know about. It might 
even cause undue anxiety, disputes and disruption within 
the family. 
In contrast to the above are certain genetic conditions 
which impose a serious and immediate health risk. An 
example is familial ademomatous polyposis which 
predisposes to colon cancer, a disease Which , in this 
particular situation, is entirely preventable by timely 
investigation. In such a situation the doctor, usually with 
the co-operation of relatives, can certainly put aside 
some of the classical constraints and go into great 
lengths to identify relatives at risk who could be saved 
from a life-threatening situation. 
Should individuals with pre-mutations 
be informed? 
A very delicate situation arises in the case of pre­
mutations, which may be found in a certain type of 
genetic mutation known as trinucleotide repeat 
expansion. The most important example is familial 
mental retardation commonly known as the fragile X 
I 
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syndrome. A pre-mutation is a gene which is in the 
process of undergoing expansion to a full, disease­
causing mutation. Carriers of a pre-mutation would not 
be at risk of developing the disease; their children might 
also be spared but the disease might appear in the next 
and future generations. Should such individuals be 
informed? Undoubtedly this will be a source of great 
anxiety. These individuals would feel responsible for 
such a serious condition appearing in future generations. 
However, any person who wants to have a particular test 
is entitled to know the whole truth, however painful that 
might be. The problems that are likely to arise should be 
anticipated and dealt with in the counselling which leads 
to infornled consent. Nevertheless the situation is a 
very delicate one that needs to be handled with great tact 
and understanding. A detailed discussion of possible 
approaches to the problem is beyond the scope of this 
brief commentary. 
The problem of obligate carriers 
A very difficult situation is that of obligate carriers. 
Some individual at risk for a dominant disease such as 
Huntington'S disease might prefer not to know whether 
they carry the mutant gene or not. They might prefer to 
live in uncertainty which also provides a measure of 
hope. The problem arises if their children want to be 
tested . A positive test in one of their sons or daughters 
would make them obligate carriers. This would be 
clearly unethical, as it would go against their expressed 
wish not to know. This situation creates one of the most 
difficult ethical dilemmas that a geneticist can encounter. 
Information to employers and 
insurance agencies 
The problem of providing genetic infornlation to 
employers or insurance agencies has been strongly 
debated. A person who gives consent to a medical 
examination for insurance or employment purposes is 
automatically giving consent to the results being 
revealed to the third party. A doctor cannot make a false 
declaration! In this case the ethical issues involve 
employers and insurance companies. The availability of 
genetic test results to such agencies would certainlj be 
disadvantageous and discriminatory to affected 
individuals . Geneticists, doctors and patients may insist 
on a code of ethics setting guidelines regarding what 
information commercial agencies can reasonably 
request. The onus of responsibility to reach a consensus 
regarding what information can reasonably be asked for 
to avoid discrimination lies squarely on these agencies. 
Paternity testing 
In cases of paternity disputes, only the individuals who 
consent to participate in the testing procedure have a 
right to know the test result . The problems of 
embarrassment, shame and possibly even torturing strain 
do not arise because of genetic tests that may have been 
performed, but from the social situations which have led 
to the need for paternity testing . These are social 
problems. The moral and ethical issues, which may arise, 
are ones of inter-personal relationships. Rather than 
being the cause of embarrassment a paternity test result 
will resolve uncertainty and may help in re-establishing a 
degree of stability for the disputing parties and the child. 
Genetic intervention 
Perhaps the most important ethical issue relating to 
individuals with genetic disease is the extent to which 
medico-scientific advances should be made freely 
available for use on individuals. Interventions that 
involve procreation would raise the most serious ethical 
problems because they involve the basic values of 
society, the respect for human dignity and the rights of 
the embryo or foetus, which in this case is the third party 
without a voice to consent. It is already evident that 
interventions involving procreation would require a 
major re-evaluation of the classical social and legal 
concepts of paternity and maternity and families. 
Undoubtedly new major ethical problems are bound to 
crop up as the advance of genetics continues in its 
exponential trend. Undoubtedly they will raise 
controversy and dispute until the problems are resolved 
as they have been in the past. However, the big ethical 
problems will not stem from the human genome project 
or problems of confidentiality. The major ethical issue 
that is likely to become of crucial importance in the near 
future will centre on the modification or regulation of an 
unborn person's genetic constitution by genetic 
manipulation of the germ cells. The techniques of 
cloning and transgenic manipulation are already lurking 
in the background . 
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